Literature DB >> 16279352

The fallback procedure for evaluating a single family of hypotheses.

Brian L Wiens1, Alexei Dmitrienko.   

Abstract

In testing multiple hypotheses, control of the familywise error rate is often considered. We develop a procedure called the "fallback procedure" to control the familywise error rate when multiple primary hypotheses are tested. With the fallback procedure, the Type I error rate (alpha) is partitioned among the various hypotheses of interest. Unlike the standard Bonferroni adjustment, however, testing hypotheses proceeds in an order determined a priori. As long as hypotheses are rejected, the Type I error rate can be accumulated, making tests of later hypotheses more powerful than under the Bonferroni procedure. Unlike the fixed sequence test, the fallback test allows consideration of all hypotheses even if one or more hypotheses are not rejected early in the process, thereby avoiding a common concern about the fixed sequence procedure. We develop properties of the fallback procedure, including control of the familywise error rate for an arbitrary number of hypotheses via illustrating the procedure as a closed testing procedure, as well as making the test more powerful via alpha exhaustion. We compare it to other procedures for controlling familywise error rates, finding that the fallback procedure is a viable alternative to the fixed sequence procedure when there is some doubt about the power for the first hypothesis. These results expand on the previously developed properties of the fallback procedure (Wiens, 2003). Several examples are discussed to illustrate the relative advantages of the fallback procedure.

Mesh:

Year:  2005        PMID: 16279352     DOI: 10.1080/10543400500265660

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  10 in total

1.  Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.

Authors:  Ionut Bebu; John M Lachin
Journal:  Biostatistics       Date:  2015-09-08       Impact factor: 5.899

Review 2.  Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.

Authors:  Toshimitsu Hamasaki; Scott R Evans; Koko Asakura
Journal:  J Biopharm Stat       Date:  2017-10-30       Impact factor: 1.051

3.  Relations among Three Parametric Multiple Testing Methods for Correlated Tests.

Authors:  Changchun Xie
Journal:  J Stat Comput Simul       Date:  2014-04-01       Impact factor: 1.424

4.  Adaptive graph-based multiple testing procedures.

Authors:  Florian Klinglmueller; Martin Posch; Franz Koenig
Journal:  Pharm Stat       Date:  2014-10-16       Impact factor: 1.894

5.  A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rules.

Authors:  Jian Wang; Junsheng Ma; Chunyan Cai; Naval Daver; Jing Ning
Journal:  Stat Med       Date:  2021-06-07       Impact factor: 2.497

6.  A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophrenia.

Authors:  AnnCatherine M Downing; Bruce J Kinon; Brian A Millen; Lu Zhang; Lin Liu; Margarita A Morozova; Ronald Brenner; Tami Jo Rayle; Laura Nisenbaum; Fangyi Zhao; Juan Carlos Gomez
Journal:  BMC Psychiatry       Date:  2014-12-10       Impact factor: 3.630

7.  Fallback tests for co-primary endpoints.

Authors:  Robin Ristl; Florian Frommlet; Armin Koch; Martin Posch
Journal:  Stat Med       Date:  2016-02-25       Impact factor: 2.373

8.  Sample sizes for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control including for COVID-19.

Authors:  Franklin Dexter; Johannes Ledolter; Russell T Wall; Subhradeep Datta; Randy W Loftus
Journal:  Perioper Care Oper Room Manag       Date:  2020-05-21

9.  Effects of a Patient Activation Tool on Decision Making Between Surgery and Nonoperative Management for Pediatric Appendicitis: A Randomized Clinical Trial.

Authors:  Peter C Minneci; Jennifer N Cooper; Karen Leonhart; Kristine Nacion; Jason Sulkowski; Kyle Porter; Lai Wei; Katherine J Deans
Journal:  JAMA Netw Open       Date:  2019-06-05

10.  The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials.

Authors:  Janus Christian Jakobsen; Christian Gluud; Per Winkel; Theis Lange; Jørn Wetterslev
Journal:  BMC Med Res Methodol       Date:  2014-03-04       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.